272 results
Page 2 of 14
8-K
EX-99.1
em1os70clq2vhy
8 Jan 24
Other Events
1:45pm
8-K
EX-99.1
8x9qpxt daec
6 Nov 23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023
8:31am
8-K
EX-1.1
2w5m6y
2 Oct 23
Entry into a Material Definitive Agreement
5:15pm
424B5
k4d4gkbz
2 Oct 23
Prospectus supplement for primary offering
5:10pm
424B5
4n7hx5mlsr5tg q3
28 Sep 23
Prospectus supplement for primary offering
4:01pm
8-K
78drlv
13 Sep 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
mng7ghy6yfs 7y2fo
13 Sep 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
vz08r
13 Sep 23
Madrigal Pharmaceuticals Announces NDA Acceptance and Priority Review of the New Drug
4:25pm
S-8
EX-99.2
zec0 6rtio0sy9353
11 Sep 23
Registration of securities for employees
4:31pm
S-8
EX-99.3
92vmjq4ptiukrverxg94
11 Sep 23
Registration of securities for employees
4:31pm
S-8
EX-99.1
do0jwd
11 Sep 23
Registration of securities for employees
4:31pm
424B3
hjezlywvq0y96 p5cfpz
8 Aug 23
Prospectus supplement
9:19am
8-K
EX-99.1
6guc1h4
8 Aug 23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Second Quarter 2023 Financial Results
8:00am